NCT06416085View on ClinicalTrials.gov

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

January 15, 2026

Study Completion Date

June 15, 2026

Conditions
Advanced CancerStage IV Solid Tumor CancerStage IV Sarcoma of BoneStage IV LymphomaStage IV MelanomaEndocrine Cancer
Interventions
DRUG

Psilocybin

Single high-dose (25mg) capsule of psilocybin taken orally in the context of Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy

Trial Locations (1)

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER